Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient

Clinical trial NCT07223632 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07223632
Sponsor: Vanda Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Charcot Marie Tooth Disease (CMT)Neuromuscular Diseases (NMD)

Start date: 2025-05-13
Primary completion: 2027-03-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.